TransEnterix: Bringing more augmented intelligence to proceduresTransEnterix (NYSE: TRXC) announced in August that cost-saving initiatives and a $15 million underwritten public offering have provided enough cash to support operations into the second quarter of 2021.
Before the COVID-19 pandemic hit, TransEnterix had been seeking a better year for its Senhance Systems, which boast haptic feedback, surgeon camera control via eye sensing and improved ergonomics.
The company has made a push into augmented intelligence. The new FDA-cleared Intelligent Surgical Unit on the system enables the camera to automatically move for a surgeon during a procedure, responding to commands and recognizing certain objects and locations in the surgical field.
Hackensack Meridian Health Pascack Valley Medical Center in New Jersey recently completed its first surgical procedures using the Intelligent Surgical Unit.
TransEnterix has also experimented with robot leasing agreements to get Senhance into the hands of more surgeons.